Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.
Nat Biomed Eng
; 8(4): 443-460, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-38561490
ABSTRACT
Allogeneic mesenchymal stromal cells (MSCs) are a safe treatment option for many disorders of the immune system. However, clinical trials using MSCs have shown inconsistent therapeutic efficacy, mostly owing to MSCs providing insufficient immunosuppression in target tissues. Here we show that antigen-specific immunosuppression can be enhanced by genetically modifying MSCs with chimaeric antigen receptors (CARs), as we show for E-cadherin-targeted CAR-MSCs for the treatment of graft-versus-host disease in mice. CAR-MSCs led to superior T-cell suppression and localization to E-cadherin+ colonic cells, ameliorating the animals' symptoms and survival rates. On antigen-specific stimulation, CAR-MSCs upregulated the expression of immunosuppressive genes and receptors for T-cell inhibition as well as the production of immunosuppressive cytokines while maintaining their stem cell phenotype and safety profile in the animal models. CAR-MSCs may represent a widely applicable therapeutic technology for enhancing immunosuppression.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Terapia de Inmunosupresión
/
Células Madre Mesenquimatosas
/
Receptores Quiméricos de Antígenos
/
Enfermedad Injerto contra Huésped
Límite:
Animals
/
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article